XML 16 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenues        
Total revenues $ 4,846,172 $ 44,261,407 $ 18,313,206 $ 87,229,949
Operating expenses        
Cost of sales and supportive services 83,276 5,559,215 1,330,114 10,465,078
Selling, general and administrative 4,305,644 3,566,258 13,577,887 10,613,267
Research and development 3,235,145 2,073,613 7,801,901 7,933,404
Patent expenses 165,996 164,102 535,497 520,902
Total operating expenses 7,790,061 11,363,188 23,245,399 29,532,651
Operating (loss)/income (2,943,889) 32,898,219 (4,932,193) 57,697,298
(Loss)/gain from change in fair value of warrant liability (1,066,522) (1,274,156) 294,548 (2,909,808)
Loss on extinguishment of Term Loan 0 0 0 (4,981,461)
Interest expense 0 0 0 (3,016,817)
Other income, net 26,252 24,932 76,055 469,226
(Loss)/income before income taxes (3,984,159) 31,648,995 (4,561,590) 47,258,438
Benefit/(provision) for income taxes 870,801 (7,461,038) 805,328 (11,077,854)
Net and comprehensive (loss)/income $ (3,113,358) $ 24,187,957 $ (3,756,262) $ 36,180,584
Basic (loss)/income per share (in dollars per share) $ (0.04) $ 0.31 $ (0.05) $ 0.45
Diluted (loss)/income per share (in dollars per share) $ (0.04) $ 0.31 $ (0.05) $ 0.45
Weighted average shares outstanding: basic (in shares) 74,840,846 78,080,461 75,822,713 79,880,493
Weighted average shares outstanding: diluted (in shares) 74,840,846 78,168,070 76,634,963 80,051,778
Product Sales and Supportive Services [Member]        
Revenues        
Total revenues $ 2,346,110 $ 41,810,192 $ 12,793,615 $ 80,547,651
Research and Development [Member]        
Revenues        
Total revenues $ 2,500,062 $ 2,451,215 $ 5,519,591 $ 6,682,298